502 related articles for article (PubMed ID: 8326169)
21. Multidrug therapy in hospitalised leprosy cases.
Tiwari VD; Tutakne MA; Singh G; Dutta RK
Indian J Lepr; 1988 Jan; 60(1):71-6. PubMed ID: 3204277
[TBL] [Abstract][Full Text] [Related]
22. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
23. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
[TBL] [Abstract][Full Text] [Related]
24. Short term chemotherapy of paucibacillary leprosy.
Dhir R; Guha PK; Singh G
Indian J Lepr; 1986; 58(4):549-54. PubMed ID: 3572096
[TBL] [Abstract][Full Text] [Related]
25. Paucibacillary multidrug therapy in leprosy. 7 1/2 years experience.
Kaur S; Sharma VK; Basak P; Kaur I
Indian J Lepr; 1992; 64(2):153-61. PubMed ID: 1607713
[TBL] [Abstract][Full Text] [Related]
26. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
Warndorff van Diepen T; Mengistu G
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):189-97. PubMed ID: 2410520
[TBL] [Abstract][Full Text] [Related]
27. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
[TBL] [Abstract][Full Text] [Related]
28. Fixed duration MDT in paucibacillary leprosy.
Mathai R; George S; Jacob M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
[TBL] [Abstract][Full Text] [Related]
29. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
[TBL] [Abstract][Full Text] [Related]
31. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
[TBL] [Abstract][Full Text] [Related]
32. Impact of multidrug therapy on the treatment and control of leprosy.
Gilbody JS
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
[No Abstract] [Full Text] [Related]
33. [5-year assessment of daily multi-drug therapy of leprosy in Guadeloupe since 1980].
Cartel JC; Gallais JJ; Naudillon Y; Millan J; Grosset JH
Acta Leprol; 1986; 4(4):415-25. PubMed ID: 3296612
[TBL] [Abstract][Full Text] [Related]
34. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):436-44. PubMed ID: 1474282
[TBL] [Abstract][Full Text] [Related]
35. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
36. Multidrug therapy in leprosy.
Manglani PR; Arif MA
J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
[TBL] [Abstract][Full Text] [Related]
38. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
Chopra NK; Agarwal JS; Pandya PG
Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
[TBL] [Abstract][Full Text] [Related]
40. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
